Full Programme - RHD Congress

Skip to content

THURSDAY, 2 NOVEMBER

FRIDAY, 3 NOVEMBER

SATURDAY, 4 NOVEMBER

THURSDAY, 2 NOVEMBER

	Strep A Vaccines	Pathogenesis & Other Biological Insights	Clinical Presentation & Contemporary Management	Tertiary Care & Surgery
9:00 – 10:30	Opening Plenary A Global Movement to End RHD Yas Grand 1,2,3
10:30 – 11:15	Break / Poster Sessions
10:30 – 11:15
11:15 – 12:15	Symposia
11:15 – 12:15	Identifying and Developing Strep A Vaccine Candidates Yas Grand 4 Identifying and Developing Strep A Vaccine Candidates Thursday, 2 November Start time: 11:15 am End time: 12:15 pm Yas Grand 4 Chair(s) Emmy Okello Uganda Heart Institute Luiza Guilherme Univeristy of São Paulo Presentations The Landscape of Vaccine Candidates Andrew Steer (Murdoch Children’s Research Institute) SAVAC Jerome Kim (International Vaccine Institute) ASAVI Alma Fulurija (University of Western Australia, Telethon Kids Institute)	Molecular Epidemiology of Strep Infection: Insights to Better Tackle Rheumatic Heart Disease Yas Grand 5 Molecular Epidemiology of Strep Infection: Insights to Better Tackle Rheumatic Heart Disease Thursday, 2 November Start time: 11:15 am End time: 12:15 pm Yas Grand 5 Chair(s) Nikki Moreland University of Auckland Presentations The rheumatogenic emm-type concept in the light of global epidemiological data Josh Osowicki (Murdoch Children’s Research Institute) Studies on transmission in endemic regions Joselyn Rwebembera (Uganda Heart Institute) Whole genome sequencing of Strep A: Informing regional transmission pathways through longitudinal genomic epidemiology Mark Davies (University of Melbourne)	Housing, Environment, and Health: New, Novel, and Next in Primordial Prevention Yas Grand 1,2,3 Housing, Environment, and Health: New, Novel, and Next in Primordial Prevention Thursday, 2 November Start time: 11:15 am End time: 12:15 pm Yas Grand 1,2,3 Chair(s) Maylene Shung-King University of Cape Town Liesl Zühlke University of Cape Town Presentations State of the Science and Strength of the Evidence, Patient Voice. Implementation, Dissemination, Cost. Moving past ‘a disease of poverty’ to understand specific environmental risk factors for ARF and RHD development Rosemary Wyber (Telethon Kids Institute) Understanding GAS transmission pathways and opportunities to intervene. Modern insights into the pathogenesis, epidemiology, and control of GAS infections Shiranee Sriskandan (Imperial College London) How much progress have we made? Novel insights into the design and implementation of primordial prevention strategies Anna Ralph (Menzies School of Health Research) Remote community laundries – A shared vision for improved health and social impact Le Smith (Heart Foundation of Australia) Elizabeth Morgan-Brett (Aboriginal Investment Group)	Improving Access to Catheter-Based Therapies Yas Stada 1,2 Improving Access to Catheter-Based Therapies Thursday, 2 November Start time: 11:15 am End time: 12:15 pm Yas Stada 1,2 Chair(s) Ganesan Karthikeyan All India Institute of Medical Sciences Sajidah Khan University of Kwazulu-Natal Presentations Access to catheter-based therapies for RHD, capacity building and training for catheter therapies in LMICs (Magdi Yacoub lecture for advances in surgery for RHD) Krishna Kumar (Amrita Institute of Medical Sciences and Research Centre) Cost effectiveness: Aggressive preventive measures to surgical vs catheter based interventions Craig Sable (Children’s National Hospital in Washington, D.C)
12:15 – 13:30	Lunch & Poster Tour
12:15 – 13:30	LUNCH SYMPOSIUM - Sponsored by the Snow Foundation (12:15-13:15) How Philanthropy Can Support Collaborative Efforts to Progress Ending RHD Yas Grand 4
13:30 – 14:30	Symposia
13:30 – 14:30		Diagnostics and Biomarkers: How Far Along Are We? Yas Grand 5 Diagnostics and Biomarkers: How Far Along Are We? Thursday, 2 November Start time: 1:30 pm End time: 2:30 pm Yas Grand 5 Chair(s) Tom Parks Imperial College London Anna Norrby-Teglund Karolinska Institutet Presentations Biomarkers at the level of the valve Arun Bandyopadhyay (Gujarat Biotechnology University) The Potential of Antibody Biomarkers to Improve Rheumatic Fever Diagnosis Nikki Moreland (University of Auckland) Putting all in clinical context of Jones criteria and potential role of AI Andrea Beaton (Cincinnati Children’s Hospital)	Pragmatic Vs Perfect Primary Prevention Programmes Yas Grand 1,2,3 Pragmatic Vs Perfect Primary Prevention Programmes Thursday, 2 November Start time: 1:30 pm End time: 2:30 pm Yas Grand 1,2,3 Chair(s) Asha Bowen Perth Children’s Hospital Telethon Kids Institute Joselyn Rwebembera Uganda Heart Institute Presentations How do we address the issue of sub-clinical infections? (Edward Kaplan lecture for contribution to streptococcal biology) Ana Mocumbi (Universidade Eduardo Mondlane) Overview of Primary Prevention and the Dual Importance of Skin and Throat Infections Asha Bowen (Perth Children’s Hospital and Telethon Kids Institute) The Opportunity for Strep A Point-of-Care Testing to prevent ARF Bernadette Wong (Telethon Kids Institute) The Community Voice on Healthy Skin and Primary Prevention of ARF 2.5 Tracy McRae (University of Western Australia) Stephanie Enkel (University of Western Australia) What can we learn about primary prevention from SPYCATS? Edwin Armitage (London School of Hygiene and Tropical Medicine) Partnering with the community to support co-design of sore throat program Joselyn Rwebembera (Uganda Heart Institute)	Innovations in Cardiac Interventions Yas Stada 1,2 Innovations in Cardiac Interventions Thursday, 2 November Start time: 1:30 pm End time: 2:30 pm Yas Stada 1,2 Chair(s) Geu-Ru Hong Yonsei University Emmy Okello Uganda Heart Institute Presentations Need for innovations in valve therapy Mpiko Ntsekhe (University of Cape Town) Evolving surgical techniques for rheumatic mitral valve disease Bhagawan Koirala (Manmohan Cardiothoracic Vascular and Transplant Center) Need for catheter registries in LMIC Krishna Kumar (Amrita Institute of Medical Sciences and Research Centre) Imaging-based Criteria for Identifying Suitable Candidates for Percutaneous Mitral Valvuloplasty Maria Do Carmo Nunes (Federal University of Minas Gerais)
14:30 – 15:15	Break / Poster Sessions
14:30 – 15:15
15:15 – 16:15	Symposia
15:15 – 16:15	Technical Advances for Strep A Vaccine Development Yas Grand 4 Technical Advances for Strep A Vaccine Development Thursday, 2 November Start time: 3:15 pm End time: 4:15 pm Yas Grand 4 Chair(s) Jonathan Carapetis Telethon Kids Institute Presentations Development and validation of multiplexed electrochemiluminescent assays for the measurement of human immunoglobulin antibodies to group Strep antigens Alma Fulurija (University of Western Australia, Telethon Kids Institute) Characterization of a 5-plex assay to measure Streptococcus pyogenes IgA and IgG in oral fluid samples Fatoumata Camara (London School of Hygiene and Tropical Medicine) Systems serology identifies key correlates of Group A Streptococcus killing to inform vaccine development Reuben McGregor (University of Auckland) Adjuvant selection is critical to improve vaccine protection against GAS colonisation and invasive disease in animal models Tania Rivera-Hernandez (Cátedras Conacyt) Implementing Artificial Intelligence for Diagnosis of Rheumatic Disease: A Field Study Kelsey Brown (Children’s National Hospital in Washington, D.C)	Streptococcal Mechanisms: Novel Models and New Insights into Acute Rheumatic Fever and Rheumatic Heart Disease Yas Grand 5 Streptococcal Mechanisms: Novel Models and New Insights into Acute Rheumatic Fever and Rheumatic Heart Disease Thursday, 2 November Start time: 3:15 pm End time: 4:15 pm Yas Grand 5 Chair(s) Tom Parks Imperial College London Najma Latif Imperial College London Presentations Establishment of a fully characterised model of Rheumatic Heart Disease Natkunam Ketheesan (University of New England) What can models teach us about host-pathogen interaction in rheumatic pathogenesis Shiranee Sriskandan (Imperial College, London) Prospects for ex-vivo models for rheumatic heart disease Najma Latif (Imperial College London)	Start Early and Aim High: Advances in Secondary Antibiotic Prophylaxis Yas Grand 1,2,3 Start Early and Aim High: Advances in Secondary Antibiotic Prophylaxis Thursday, 2 November Start time: 3:15 pm End time: 4:15 pm Yas Grand 1,2,3 Chair(s) Sulafa Ali University of Khartoum Joseph Kado Telethon Kids Institute Presentations State of the Science and Strength of the Evidence: Patient Voice Vicki Wade (Heart Foundation of Australia) Journey on Penicillin Work Laurens Manning (University of Western Australia) Using pharmacokinetic modelling to understand and inform clinical trials for secondary prophylaxis of RHD Abdullah Al Shafi Majumder (Bangladesh Specialized Hospital Ltd) “Hurts Less, Lasts Longer”: Experiences of young people receiving high-dose subcutaneous infusions of benzathine penicillin G to prevent rheumatic heart disease Julie Bennett (University of Otago) Julie Cooper (University of Otago)	Risk Stratification Models for Valvular Surgery and Interventions Yas Stada 1,2 Risk Stratification Models for Valvular Surgery and Interventions Thursday, 2 November Start time: 3:15 pm End time: 4:15 pm Yas Stada 1,2 Chair(s) Emmy Okello Uganda Heart Institute Presentations Surgical risk stratification for patients with RHD Krishna Kumar (Amrita Institute of Medical Sciences and Research Centre) Role of Heart Valve Team: Starting discussion with a case Geu-Ru Hong (Yonsei University) Preoperative Left Ventricular Dysfunction Is a Risk Factor for Late Death in Paediatric Patients after Rheumatic Heart Disease Surgery for Isolated Aortic Valve Disease Hilary Hardefeldt (Starship Children’s Hospital)
16:30 – 17:30	Opening Ceremony Yas Grand 1,2,3

FRIDAY, 3 NOVEMBER

	Strep A Vaccines	Pathogenesis & Other Biological Insights	Clinical Presentation & Contemporary Management	Tertiary Care & Surgery
8:00 – 9:00	BREAKFAST SESSION - Sponsored by Edwards Foundation Every Heartbeat Matters: What More Can We Do to Impact Underserved RHD Patients? Yas Grand 4
9:00 – 10:30	Symposia
9:00 – 10:30	Equitable Access to Strep A Vaccines: From Testing to Implementation Yas Grand 4 Equitable Access to Strep A Vaccines: From Testing to Implementation Friday, 3 November Start time: 9:00 am End time: 10:30 am Yas Grand 4 Chair(s) Shiranee Sriskandan Imperial College London Presentations Animal and human challenge models Josh Osowicki (Murdoch Children’s Research Institute) Considerations for accelerating equitable access to Strep A vaccines globally Thomas Cherian (MMGH Consulting) Post-licensure studies Jerome Kim (International Vaccines Initiative) The Importance of Community Engaged Design for Clinical Trial Planning and Execution Andrea Beaton (Cincinnati Children’s Hospital)	Host-Focused Mechanisms Leading to Acute Rheumatic Fever and Rheumatic Heart Disease Yas Grand 5 Host-Focused Mechanisms Leading to Acute Rheumatic Fever and Rheumatic Heart Disease Friday, 3 November Start time: 9:00 am End time: 10:30 am Yas Grand 5 Chair(s) Anna Norrby-Teglund Karolinska Institutet Presentations What do we know about molecular mimicry and RHD? Madeleine Cunningham (University of Oklahoma Health Sciences Center) Virulence potential of streptococcal M and M-like surface proteins Pierre Smeesters (Hôpital Universitaire des Enfants Reine Fabiola) Role of Group A carbohydrate and other glycans Nina van Sorge (Amsterdam UMC) RHD and host genetics Tom Parks (Imperial College London)	The Know-Do Gap: Implementing and Disseminating Best Practices Yas Grand 1,2,3 The Know-Do Gap: Implementing and Disseminating Best Practices Friday, 3 November Start time: 9:00 am End time: 10:30 am Yas Grand 1,2,3 Chair(s) Sulafa Ali University of Khartoum Krishna Kumar Amrita Institute of Medical Sciences and Research Centre Presentations Keynote address (Padmavati – Roy – Bhatia – Tandon lecture for Global Influence in the Field of RHD): Liesl Zühlke University of Cape Town Emmy Okello Uganda Heart Institute Oyoo Charles Akiya Ministry of Health of Uganda Poonam Pal Ministry of Health and Medical Services of Fiji Management of severe rheumatic mitral and aortic regurgitation in the young Nigel Wilson (Starship Children’s Hospital)	More in Medical Therapies for Rheumatic Heart Disease Yas Stada 1,2 More in Medical Therapies for Rheumatic Heart Disease Friday, 3 November Start time: 9:00 am End time: 10:30 am Yas Stada 1,2 Chair(s) Bo Remenyi Royal Darwin Hospital Presentations Anticoagulation for atrial fibrillation in RHD after INVICTUS (Bongani Mayosi lecture for leadership in clinical trials) Ganesan Karthikeyan (All India Institute of Medical Sciences) Medical management of heart failure Joselyn Rwebembera (Uganda Heart Institute) Care for RHD-affected young women Ana Mocumbi (Universidade Eduardo Mondlane) New Formulations Laurens Manning (University of Western Autralia) Novel therapeutics for ARF and RHD: Lessons from HCQ4ARF study Rachel Webb (University of Auckland)
10:30 – 11:15	Break / Poster Sessions
11:15 – 12:15	Plenary Priority Setting for Strep A Vaccines Yas Grand 1,2,3
12:15 – 13:30	Lunch & Poster Tour
13:30 – 14:30	Symposia
13:30 – 14:30	Vaccines Safety Yas Grand 4 Vaccines Safety Friday, 3 November Start time: 1:30 pm End time: 2:30 pm Yas Grand 4 Chair(s) Shiranee Sriskandan Imperial College London Presentations The importance of safety in Strep A: Key considerations Shiranee Sriskandan (Imperial College London) The risk-benefit balance in vaccine development from the perspective of people living with RHD Erini Tokarua (Cure Kids) Vaccines Hesitancy and Key Considerations for Development Katie Attwell (University of Western Australia) *Safety assessment pathways for Streptococcus pyogenes* vaccines – learning from history Andrew Steer (Murdoch Children’s Research Institute) A plasma protein biomarker for ARF** Emmy Okello (Uganda Heart Institute)	The Neglected Stage of a Neglected Disease: Insights and Innovations for Tackling Rheumatic Fever Yas Grand 5 The Neglected Stage of a Neglected Disease: Insights and Innovations for Tackling Rheumatic Fever Friday, 3 November Start time: 1:30 pm End time: 2:30 pm Yas Grand 5 Chair(s) Jagat Narula World Heart Federation Presentations Basic Science: New ways of diagnosing RF Anna Ralph (Menzies School of Health Research) Clinical Research: Simplified criteria for RHD Bo Remenyi (Royal Darwin Hospital) Silent Acute Rheumatic Fever Revealed by Handheld Echocardiography Sulafa Ali (University of Khartoum) Clinical Decision-making for Heart Failure in RHD: ARF, Worsening Disease, or else? Anita Saxena (Pt. BD Sharma University of Health Sciences)		Community Action to Drive Access to Catheter and Surgery Yas Stada 1,2 Community Action to Drive Access to Catheter and Surgery Friday, 3 November Start time: 1:30 pm End time: 2:30 pm Yas Stada 1,2 Chair(s) Ana Mocumbi Universidade Eduardo Mondlane Presentations Establishing Valvular Heart Disease Programs in Developing World: Why and How? Mohammad Abdelghani (Al-Azhar University) Improving Access to Cardiac Surgery for the Six Billion Without Dominique Vervoort (University of Toronto) Impact of Patient support groups on care Flavia Baturine Kamalembo (Uganda Heart Institute) Understanding the lived experience and its impact Anu Gomanju (NCDI Poverty Network, Kathmandu Institute of Child Health and Global ARCH)
14:30 – 15:15	Break / Poster Sessions
15:15 – 16:15	Plenary Establishing Integrated National Rheumatic Heart Disease Programmes Yas Grand 1,2,3
16:15 – 17:30	Symposia
16:15 – 17:30	The Latest in Strep A Vaccine Development (Abstract Session) Yas Grand 4 The Latest in Strep A Vaccine Development Friday, 3 November Start time: 4:15 pm End time: 5:30 pm Yas Grand 4 Chair(s) Alma Fulurija University of Western Australia Telethon Kids Institute Presentations Back to the future: Lessons from early twentieth century scarlet fever outbreaks for modern vaccine development Josh Osowicki (Murdoch Children’s Research Institute) Development of a Peptide-based vaccine to prevent rheumatic heart disease Michael Good (Griffith University) Facilitating Strep A Vaccine Development for Aotearoa New Zealand Nikki Moreland (University of Auckland) Platform for the recombinant production of group A streptococcus gylcoconjugate vaccines Helge Dorfmuller (University of Dundee) *A Glycolipidated-liposomal peptide vaccine confers long-term mucosal protection against Streptococcus pyogenes* via IL-17, macrophages and neutrophils** Manisha Pandey (University of Griffith)	SPECIAL SESSION Voices of RHD: Learning from Lived Experiences Yas Grand 1,2,3 Voices of RHD: Learning from Lived Experience Friday, 3 November Start time: 4:15 pm End time: 5:30 pm Yas Grand 1,2,3 Chair(s) Vicki Wade Heart Foundation of Australia Anu Gomanju NCDI Poverty Network Kathmandu Institute of Child Health Global ARCH Presentations Subjective wellbeing among rheumatic heart disease patients at Tikur Anbessa Specialized Hospital, Addis Ababa, Ethiopia: Observational cross-sectional study Henok Tadele (Addis Ababa University) Increasing knowledge and awareness for the prevention of rheumatic fever and rheumatic heart disease through school-based education activities in an endemic country Keila Jamal (Mozambique Institute for Health Education and Research) Rheumatic heart disease patient voices from the Pacific: A mixed methods study from Fiji Jyotishna Mani (Cure Kids) Anticoagulation management of postoperative rheumatic heart disease patients in Rwanda Nicole Schulick (University of Colorado) Kenya McAdam Champions4Change Henrique Thomas Champions4Change Flavia Baturine Kamalembo Uganda Heart Institute Erini Tokarua Cure Kids	Is Digital Health the Future? Innovations and Opportunities in Rheumatic Heart Disease Yas Stada 1,2 Is Digital Health the Future? Innovations and Opportunities in Rheumatic Heart Disease Friday, 3 November Start time: 4:15 pm End time: 5:30 pm Yas Stada 1,2 Chair(s) Andrea Beaton Cincinnati Children’s Hospital Presentations Mobile RHD Registries Emmy Okello (Uganda Heart Institute) The Potential of Digital Technology and AI for the Rapid Diagnosis of GAS Pharyngitis Joselyn Rwebembera (Uganda Heart Institute) Opportunities and challenges in imaging for RHD Maria Do Carmo Nunes (Federal University of Minas Gerais) Delivering equitable and appropriate echocardiography in a multi-ethnic world Gillian Whalley (University of Otago)
17:45 - 19:00	FILM SCREENING 'Take Heart: Deadly Heart' Yas Grand 1,2,3

SATURDAY, 4 NOVEMBER

	Strep A Vaccines	Pathogenesis & Other Biological Insights	Clinical Presentation & Contemporary Management	Tertiary Care & Surgery
9:00 – 10:30	Plenary What Does Rheumatic Heart Disease Research Look Like in 10 Years’ Time? Yas Grand 1,2,3
10:30 – 11:15	Break / Poster Sessions
11:15 – 12:15	Plenary A Global Action Plan for Rheumatic Heart Disease Yas Grand 1,2,3
12:15 – 13:30	Lunch & Poster Tour
13:30 – 14:30	Symposia
13:30 – 14:30	Measuring and communicating the value of Strep A vaccines Yas Grand 4 Measuring and communicating the value of Strep A vaccines Saturday, 4 November Start time: 1:30 pm End time: 2:30 pm Yas Grand 4 Chair(s) Anshu Banerjee World Health Organization Maylene Shung-King University of Cape Town Presentations The value of vaccination from a health and healthcare perspective Jeffrey Cannon (Telethon Kids Institute) Building the case for biopharma industry investment in Strep A vaccine development Don Walkinshaw (Shift Health) Communicating the Value of Group A Streptococcus Vaccine Research and Development: Full Benefits and Innovation Daniel Tortorice (College of the Holy Cross)	The Epidemiology and Burden of RHD and Other Strep A Diseases: New Insights Yas Grand 5 The Epidemiology and Burden of RHD and Other Strep A Diseases: New Insights Saturday, 4 November Start time: 1:30 pm End time: 2:30 pm Yas Grand 5 Chair(s) Rosemary Wyber Telethon Kids Institute Presentations The global burden of RHD David Watkins (University of Washington) Epidemiology of bacterial skin infections in primary healthcare in Auckland, New Zealand Krishtika Mala (University of Otago) Prevalence of rheumatic heart disease in Senegalese school children: A clinical and echocardiographic screening Aliou Assane Ngaide (Cheikh Anta DIOP University of Dakar) The burden of RHD in India: An overview Rajesh Beniwal (Calendula Healthcare Ltd)	The Importance and Implications of Early Rheumatic Heart Disease Detection and Treatment Yas Grand 1,2,3 The Importance and Implications of Early Rheumatic Heart Disease Detection and Treatment Saturday, 4 November Start time: 1:30 pm End time: 2:30 pm Yas Grand 1,2,3 Chair(s) Liesl Zühlke University of Cape Town Presentations The importance of publishing evidence-based guidelines (Gene Stollerman lecture for advances in research) Greg Lim (Nature Reviews Cardiology) All you need to know about the new 2023 World Heart Federation Guidelines for echocardiographic diagnosis of RHD Joselyn Rwebembera (Uganda Heart Institute) Updates in the role of secondary antibiotic prophylaxis in latent RHD Andrea Beaton (Cincinnati Children’s Hospital)
14:30 – 15:30	Closing Ceremony Call to Action on Ending RHD Yas Grand 1,2,3

worldheartfederation

Follow us on Instagram

[instagram-feed feed=1]

© World Heart Federation 2024